Federal Register / Vol. 89, No. 224 / Wednesday, November 20, 2024 / Notices 91773 

MPA, Executive Secretary, NCVHS, 

National Center for Health Statistics, 

Centers for Disease Control and 

Prevention, 3311 Toledo Road, 

Hyattsville, Maryland 20782, or via 

electronic mail to nmichaelis@cdc.gov; 

or by telephone (301) 458–4202. 

Summaries of meetings and a roster of 

Committee members are available on the 

NCVHS website https://ncvhs.hhs.gov/, 

where further information including an 

agenda and instructions to access the 

broadcast of the meeting will be posted. 

Should you require reasonable 

accommodation, please telephone the 

CDC Office of Equal Employment 

Opportunity at (770) 488–3210 as soon 

as possible. 

SUPPLEMENTARY INFORMATION: As 

outlined in its Charter, the National 

Committee on Vital and Health 

Statistics assists and advises the 

Secretary of HHS on health data, data 

standards, statistics, privacy, national 

health information policy, and the 

Department’s strategy to best address 

those issues. The original authorities of 

NCVHS are described at 42 U.S.C. 242k. 

Additional authorities were added by 

the Health Insurance Portability and 

Accountability Act of 1996 (HIPAA, 

Pub. L. 104–191, 110 Stat. 1936, Aug. 

21, 1996), under which NCVHS advises 

the Secretary on administrative 

simplification standards, including 

those for privacy, security, adoption and 

implementation of transaction 

standards, unique identifiers, code sets, 

and operating rules adopted under the 

Patient Protection and Affordable Care 

Act (ACA, Pub. L. 111–148, 124 Stat. 

119, Mar. 23, 2010). Included in HIPAA 

is the statutory reporting requirement 

that the Committee submit to Congress 

and make public, a report regarding the 

implementation of part C of title XI of 

the Social Security Act. 

Purpose: Topics on the meeting 

agenda will include updates from the 

Department and the ICD–11 Workgroup. 

The Subcommittee on Privacy, 

Confidentiality, and Security will 

continue its inquiry into and discussion 

of Privacy and Security in Health Data 

Access. The Subcommittee on 

Standards will report on its current and 

future activities. The Committee will 

reserve time on the agenda for public 

comment. Meeting times and topics are 

subject to change. Please refer to the 

tentative agenda that will be posted on 

the NCVHS website at this link https:// 

ncvhs.hhs.gov/meetings/full-committeemeeting-22/ for updates. 

Laina Bush, 

Deputy Assistant Secretary, Office of Science 

and Data Policy, Office of the Assistant 

Secretary for Planning and Evaluation. 

[FR Doc. 2024–27049 Filed 11–19–24; 8:45 am] 

BILLING CODE 4150–05–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke; Amended Notice 

of Meeting 

Notice is hereby given of a change in 

the meeting of the National Institute of 

Neurological Disorders and Stroke 

Special Emphasis Panel; R13 Review, 

November 21, 2024, 10:00 a.m. to 

November 22, 2024, 05:00 p.m., 

National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD, 20852 which 

was published in the Federal Register 

on October 24, 2024, FR Doc. 2024– 

24884, 89 FR 85223. 

This notice is being amended to 

change the dates of this two-day 

meeting to December 2, 2024, and 

December 3, 2024. The meeting time 

remains the same. The meeting is closed 

to the public. 

Dated: November 14, 2024. 

David W. Freeman, 

Supervisory Program Analyst, Office of 

Federal Advisory Committee Policy. 

[FR Doc. 2024–27045 Filed 11–19–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Lifestyle 

change, Biobehavioral Medicine, and Health 

Outcomes. 

Date: December 12, 2024. 

Time: 11:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Kristen Prentice, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3112, 

MSC 7808, Bethesda, MD 20892, (301) 496– 

0726, email: prenticekj@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Behavioral 

Motor Function. 

Date: December 12, 2024. 

Time: 11:00 a.m. to 12:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Stephanie Christine Nagle 

Emmens, Ph.D., Scientific Review Officer, 

Center for Scientific Review, National 

Institutes of Health, 6701 Rockledge Drive, 

Bethesda, MD 20892, (301) 594–6604, email: 

nagleemmenssc@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: November 14, 2024. 

Bruce A. George, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–27004 Filed 11–19–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Prospective Grant of Exclusive 

License, Inter-Institutional AgreementInstitution Lead: Peptides and Peptide 

Microarrays for Detection and 

Differentiation of Antibody Responses 

to Ebola Virus and Other Pathogens. 

AGENCY: National Institutes of Health, 

National Institute of Allergy and 

Infectious Diseases. 

ACTION: Notice. 

SUMMARY: The National Institute of 

Allergy and Infectious Diseases, an 

institute of the National Institutes of 

Health, Department of Health and 


khammond on DSK9W7S144PROD with NOTICES